ArticleRenal failure2025

Evaluating the efficacy of basiliximab versus no induction in low-immunological-risk kidney transplant recipients: a propensity score matched analysis.

Dahao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.